Skip to main content
. 2024 Aug 14;86(10):5938–5946. doi: 10.1097/MS9.0000000000002478

Figure 1.

Figure 1

Advantages and limitations of traditional treatment options and gene therapy with CRISPR/Cas9 for sickle cell disease. (Created with biorender.com).